ACT-03

N/A

Report date: 2026/01/08 17:58:11
NME

Base Information

Drug NameACT-03
Drug Alias NameACT-03
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMatrix metalloproteinase-2 inhibitorsMatrix metalloproteinase 9 inhibitors
TargetsMatrix metalloproteinase-2Matrix metalloproteinase 9
Therapy Area/IndicationsEpilepsy
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySpain
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesIproteos Investment SLAccure Therapeutics SL
China Registration ClassN/A

Develop Information

Active CompaniesIproteos Investment SLAccure Therapeutics SL
Inactive CompaniesN/A
Active IndicationsEpilepsy
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A